Pathophysiology of COVID-19-associated acute kidney injury

M Legrand, S Bell, L Forni, M Joannidis… - Nature Reviews …, 2021 - nature.com
Although respiratory failure and hypoxaemia are the main manifestations of COVID-19,
kidney involvement is also common. Available evidence supports a number of potential …

Neutrophil Extracellular Traps (NETs) and Covid-19: A new frontiers for therapeutic modality

HM Al-Kuraishy, AI Al-Gareeb, HA Al-Hussaniy… - International …, 2022 - Elsevier
Abstract Coronavirus disease 2019 (Covid-19) is a worldwide infectious disease caused by
severe acute respiratory coronavirus 2 (SARS-CoV-2). In severe SARS-CoV-2 infection …

[HTML][HTML] Rationale for the use of N‐acetylcysteine in both prevention and adjuvant therapy of COVID‐19

S De Flora, R Balansky, S La Maestra - The FASEB journal, 2020 - ncbi.nlm.nih.gov
COVID‐19 may cause pneumonia, acute respiratory distress syndrome, cardiovascular
alterations, and multiple organ failure, which have been ascribed to a cytokine storm, a …

[HTML][HTML] Circulating exosomes are strongly involved in SARS-CoV-2 infection

E Barberis, VV Vanella, M Falasca… - Frontiers in molecular …, 2021 - frontiersin.org
Knowledge of the host response to the novel coronavirus SARS-CoV-2 remains limited,
hindering the understanding of COVID-19 pathogenesis and the development of therapeutic …

Dietary supplements and nutraceuticals under investigation for COVID-19 prevention and treatment

R Lordan, HM Rando, CS Greene - Msystems, 2021 - Am Soc Microbiol
ABSTRACT Coronavirus disease 2019 (COVID-19) has caused global disruption and a
significant loss of life. Existing treatments that can be repurposed as prophylactic and …

Circulating platelet-derived extracellular vesicles are a hallmark of Sars-Cov-2 infection

G Cappellano, D Raineri, R Rolla, M Giordano… - Cells, 2021 - mdpi.com
Sars-Cov-2 infection causes fever and cough that may rapidly lead to acute respiratory
distress syndrome (ARDS). Few biomarkers have been identified but, unfortunately, these …

Potential role of antioxidant and anti-inflammatory therapies to prevent severe SARS-Cov-2 complications

AM Fratta Pasini, C Stranieri, L Cominacini, C Mozzini - Antioxidants, 2021 - mdpi.com
The coronavirus disease 2019 (COVID-19) pandemic is caused by a novel severe acute
respiratory syndrome (SARS)-like coronavirus (SARS-CoV-2). Here, we review the …

Коагулопатия при COVID-19

ГМ Галстян - Пульмонология, 2020 - journal.pulmonology.ru
Аннотация Нарушения гемостаза играют важную роль в патогенезе и клинических
проявлениях COVID-19. Целью работы явилось подробное рассмотрение патогенеза …

Functional pathophysiology of SARS-CoV-2-induced acute lung injury and clinical implications

NM Habashi, L Camporota… - Journal of applied …, 2021 - journals.physiology.org
The worldwide pandemic caused by the SARS-CoV-2 virus has resulted in over 84,407,000
cases, with over 1,800,000 deaths when this paper was submitted, with comorbidities such …

[HTML][HTML] Can N-3 polyunsaturated fatty acids be considered a potential adjuvant therapy for COVID-19-associated cardiovascular complications?

AM Darwesh, W Bassiouni, DK Sosnowski… - Pharmacology & …, 2021 - Elsevier
Abstract Coronavirus disease 2019 (COVID-19), caused by the Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS-CoV-2), has currently led to a global pandemic with …